A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...

When it comes to detecting cancer, you want the fastest detection possible in order to treat it accurately and in a timely ...

Vir Biotechnology lands a license agreement with Japan’s Astellas Pharma for its lead drug candidate.

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

The new drug uses a so-called cloaking device and only activates when it reaches the tumour ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

Lord Brady of Altrincham has been successfully treated for prostate cancer, as he joined calls for a national screening programme to prevent needless deaths. The former chairman of the 1922 Committee ...

Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small ...

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. | Astellas is aiding Vir ...